Potentiation of drug response

Details Potentiation of drug response Potentiation of drug response

1995-05-17

1996-07-02

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514211, 5142242, 5142305, 514259, 514312, 514367, 514373, 514375, 514394, 514406, 514418, 514438, 514443, 514624, 514652, 514654, H61K 31135, H61K 31165, H61K 3138, H61K 31395

Patent

active

055322646

ABSTRACT:
The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.

REFERENCES:
patent: 3155669 (1964-11-01), Janssen
patent: 3155670 (1964-11-01), Janssen
patent: 3337628 (1967-08-01), Crowther et al.
patent: 3466325 (1969-09-01), Brandstrom et al.
patent: 3471515 (1969-10-01), Toxler et al.
patent: 3551493 (1970-12-01), Ruschig et al.
patent: 3960891 (1976-06-01), Malen et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4478836 (1984-10-01), Mouzin et al.
patent: 4761501 (1988-08-01), Husbands et al.
patent: 4956388 (1990-09-01), Robertson et al.
patent: 4988814 (1991-01-01), Abou-Gharbia et al.
patent: 5013761 (1991-05-01), Beedle et al.
Cliffe, et al., J. Med. Chem., 36, 1509-1510 (1993).
Moret, et al., Neuropharmacology, 24, 1211-1219 (1985).
Middlemiss, et al., Neuroscience & Biobehavioral Reviews, 16, 75-82 (1992).
Artigas, TiPs, 14, 262 (1993).
Fuller, Life Sciences, 55, 163-167 (1994).
Jacobsen, J. Clin. Psychiatry, 52, 217-220 (1991).
Robertson, et al., J. Med. Chem., 31, 1412-1417 (1988).
Hillver, et al., J. Med. Chem., 33, 1541-1544 (1990).
Moreau, et al., Brain Research Bulletin, 29, 901-904 1992.
Hjorth, Journal of Neurochemistry, 60, 776-779 (1993).
Artigas, et al., Arch. Gen. Psychiatry, 51, 248-251 (1994).
Invernizzi, et al, Brain Research, 584, 322-324 (1992).
Bosker, et al., Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 18, 765-778 (1994).
Tang, et al., Psychiatry Research, 33, 101-106 (1990).
Davidson, et al., J. Psychopharmacol. Abstracts, A7 (1994).
Arborelius, et al., Psychopharmacology (Berlin), 114, B14 (1994).
David Bakish, Can. J. Psychiatry, 36, 749-750 (1991).
Markovitz, et al., Am. J. Psychiatry, 147, 798-800 (1990).
Li, et al., Biol. Psychiatry, 36, 300-308 (1994).
Simon, et al., Neuroreport, 5, 229-230 (1993).
Maj, et al., J. Neural. Transm. [Gen Sect], 88, 143-156 (1992).
Hjorth, et al., Eur. J. Pharmacol., 260, 251-255 (1994).
Invernizzi, et al., Eur. J. Pharmacol., 260, 243-246 (1994).
Hjorth, et al., Neuropharmacology, 33, 331-334 (1994).
Klimek, et al., J. Psychiatry Neurosci., 19, 63-67 (1994).
Li, et al., Brain Research, 630, 148-156 (1993).
Bjorvatn, et al., Pharmacol. Biochem. Behav., 42, 49-56 (1992).
Lesch, et al., Psychopharmacology (Berlin), 105, 415-420 (1991).

Affiliated with

Also associated with

Rating

Potentiation of drug response does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Potentiation of drug response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potentiation of drug response will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1506762